CAR T-cell therapy shows promise for patients with lupus

For patients with systemic lupus erythematosus (SLE), chimeric antigen receptor T-cell (CAR T-cell) therapy is associated with consistent reductions in disease activity, according to research presented at the annual meeting ...

page 1 from 24